RELATIONSHIP BETWEEN FINANCIAL IMPACT AND COVERAGE OF DRUGS IN AUSTRALIA
Open Access
- 10 December 2012
- journal article
- Published by Cambridge University Press (CUP) in International Journal of Technology Assessment in Health Care
- Vol. 29 (1), 92-100
- https://doi.org/10.1017/s0266462312000724
Abstract
Objectives: The aim of this study was to estimate the relationship between the financial impact of a new drug and the recommendation for reimbursement by the Australian Pharmaceutical Benefits Advisory Committee (PBAC).Methods: Data in the PBAC summary database were abstracted for decisions made between July 2005 and November 2009. Financial impact—the upper bound of the values presented in the PBAC summary database—was categorized as ≤A$0, >A$0 up to A$10 million, A$10 million up to A$30 million, and >A$30 million per year. Descriptive, logistic, survival, and recursive partitioning decision analyses were used to estimate the relationship between the financial impact of a new drug indication and the recommendation for reimbursement. Multivariable analyses controlled for other clinical and economic variables, including cost per quality-adjusted life-year gained.Results: Financial impact was a significant predictor of the recommendation for reimbursement. In the logistic analysis, the odds ratios of reimbursement for drug submissions with financial impacts ≥A$10 million to ≥A$30 million or >A$0 to Conclusions: In Australia, financial impact on the drug budget is an important determinant of whether a new drug is recommended for reimbursement when cost-effectiveness estimates and other clinical and economic variables are controlled.Keywords
This publication has 15 references indexed in Scilit:
- Recursive partitioning analysis of prognostic factors for glioblastoma patients aged 70 years or olderCancer, 2012
- Are Cancer Drugs Less Likely to be Recommended for Listing by the Pharmaceutical Benefits Advisory Committee in Australia?PharmacoEconomics, 2010
- An introduction to recursive partitioning: Rationale, application, and characteristics of classification and regression trees, bagging, and random forests.Psychological Methods, 2009
- Using Effectiveness and Cost-effectiveness to Make Drug Coverage DecisionsJama-Journal Of The American Medical Association, 2009
- Finding legitimacy for the role of budget impact in drug reimbursement decisionsInternational Journal of Technology Assessment in Health Care, 2009
- The Role of Value for Money in Public Insurance Coverage Decisions for Drugs in Australia: A Retrospective Analysis 1994-2004Medical Decision Making, 2008
- Role of Budget Impact in Drug Reimbursement DecisionsJournal of Health Politics, Policy and Law, 2008
- Principles of Good Practice for Budget Impact Analysis: Report of the ISPOR Task Force on Good Research Practices—Budget Impact AnalysisValue in Health, 2007
- Prevalence-Based Economic EvaluationValue in Health, 1998
- Applied Logistic RegressionTechnometrics, 1992